Explore
Validate
LearnABIN361848
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN361848 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN361848, RRID:AB_10791428
- Product name
- anti-MAP kinase p38 (p38) antibody
- Antibody type
- Polyclonal
- Description
- Peptide Affinity Purified
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Chicken/Avian, Guinea Pig, Hamster, Porcine, Rabbit, Sheep, Simian
- Host
- Rabbit
- Vial size
- 100 μL
- Storage
- -20°C
Submitted references Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione.
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.
Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes.
A JNK-dependent pathway is required for TNFalpha-induced apoptosis.
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Fan Y, Chen H, Qiao B, Luo L, Ma H, Li H, Jiang J, Niu D, Yin Z
Molecules and cells 2007 Feb 28;23(1):30-8
Molecules and cells 2007 Feb 28;23(1):30-8
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
Medicherla S, Protter AA, Ma JY, Mangadu R, Almirez R, Koppelman B, Kerr I, Navas TA, Movius F, Reddy M, Liu YW, Luedtke G, Perumattam J, Mavunkel B, Dugar S, Schreiner GF
The Journal of pharmacology and experimental therapeutics 2006 Jul;318(1):99-107
The Journal of pharmacology and experimental therapeutics 2006 Jul;318(1):99-107
Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.
Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T
Journal of immunology (Baltimore, Md. : 1950) 2006 Feb 1;176(3):1899-907
Journal of immunology (Baltimore, Md. : 1950) 2006 Feb 1;176(3):1899-907
Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes.
Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, Vandenheede JR, Garmyn M, Agostinis P
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004 Dec;18(15):1946-8
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004 Dec;18(15):1946-8
A JNK-dependent pathway is required for TNFalpha-induced apoptosis.
Deng Y, Ren X, Yang L, Lin Y, Wu X
Cell 2003 Oct 3;115(1):61-70
Cell 2003 Oct 3;115(1):61-70
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH
Endocrine reviews 2001 Apr;22(2):153-83
Endocrine reviews 2001 Apr;22(2):153-83
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Han J, Lee JD, Bibbs L, Ulevitch RJ
Science (New York, N.Y.) 1994 Aug 5;265(5173):808-11
Science (New York, N.Y.) 1994 Aug 5;265(5173):808-11
No comments: Submit comment
No validations: Submit validation data